Speaker: P. Kelly Marcom, MD | Medical Director-Breast Cancer, Veracyte Understand the potential of Prosignaⓐ

• Discuss the advantages of using a second-generation genomic test
• Learn about the utility of intrinsic subtyping in the clinic
• Live discussion and debates looking at the past, present and future.

 
^{*This session is intended for physicians practicing outside of the U.S., however, U.S.-based physician’s are welcome to attend.​}

Speakers: Charles M. Perou, PhD, Prof. Torsten O. Nielsen and Dr. phil. Martina Kirchner

• Understand the history and origin of PAM50 & Prosigna
• Discuss their evolution from the laboratory to the clinic
• Learn how accurate biological classification can be used to best treat your patients

 
^{*This session is intended for physicians practicing outside of the U.S., however, U.S.-based physician’s are welcome to attend.​}

^{*This session is intended for physicians practicing outside of the U.S., however, U.S.-based physician’s are welcome to attend.​}

• Professor Mark Beresford – Clinical Oncologist
• Dr Marina Parton – Medical Oncologist
• Dr Judy King – Medical Oncologist
• Professor Abeer Shaaban – Breast Pathologist
• Mr James Harvey – Breast Surgeon

 
^{*This session is intended for physicians practicing outside of the U.S., however, U.S.-based physician’s are welcome to attend.​}